Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| plasma cell | 13 studies | 61% ± 26% | |
| B cell | 9 studies | 36% ± 12% | |
| naive B cell | 8 studies | 27% ± 9% | |
| IgA plasma cell | 6 studies | 38% ± 15% | |
| plasmablast | 4 studies | 63% ± 17% | |
| IgG plasma cell | 4 studies | 30% ± 5% | |
| immature B cell | 3 studies | 44% ± 18% | |
| precursor B cell | 3 studies | 62% ± 13% |
Insufficient scRNA-seq data for expression of IGLL5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lymph node | 0% | 0 | 0 / 0 | 90% | 133.43 | 26 / 29 |
| lung | 0% | 0 | 0 / 0 | 81% | 7.01 | 936 / 1155 |
| tonsil | 0% | 0 | 0 / 0 | 78% | 8.29 | 35 / 45 |
| stomach | 0% | 0 | 0 / 0 | 63% | 5.22 | 179 / 286 |
| intestine | 0% | 0 | 0 / 0 | 59% | 4.42 | 312 / 527 |
| esophagus | 0% | 0 | 0 / 0 | 49% | 3.07 | 90 / 183 |
| pancreas | 0% | 0 | 0 / 0 | 49% | 2.77 | 87 / 178 |
| bladder | 0% | 0 | 0 / 0 | 48% | 2.65 | 240 / 504 |
| skin | 0% | 0 | 0 / 0 | 46% | 3.77 | 215 / 472 |
| breast | 0% | 0 | 0 / 0 | 45% | 2.20 | 507 / 1118 |
| uterus | 0% | 0 | 0 / 0 | 41% | 2.05 | 190 / 459 |
| ovary | 0% | 0 | 0 / 0 | 33% | 1.77 | 141 / 430 |
| thymus | 0% | 0 | 0 / 0 | 30% | 2.26 | 183 / 605 |
| kidney | 0% | 0 | 0 / 0 | 18% | 1.03 | 162 / 901 |
| liver | 0% | 0 | 0 / 0 | 12% | 0.52 | 50 / 406 |
| prostate | 0% | 0 | 0 / 0 | 11% | 0.34 | 55 / 502 |
| eye | 0% | 0 | 0 / 0 | 6% | 0.53 | 5 / 80 |
| adrenal gland | 0% | 0 | 0 / 0 | 6% | 0.18 | 13 / 230 |
| brain | 0% | 0 | 0 / 0 | 1% | 0.12 | 8 / 705 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| muscle | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0016064 | Biological process | immunoglobulin mediated immune response |
| GO_0071735 | Cellular component | IgG immunoglobulin complex |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0003823 | Molecular function | antigen binding |
| Gene name | IGLL5 |
| Protein name | Immunoglobulin lambda like polypeptide 5 Immunoglobulin lambda-like polypeptide 5 (G lambda-1) (Germline immunoglobulin lambda 1) |
| Synonyms | |
| Description | |
| Accessions | B9A064 A0A0B4J231 ENST00000532223.2 ENST00000526893.6 [B9A064-1] ENST00000531372.1 [B9A064-2] |